GSK, Pfizer and RSV

Pfizer Inc. (NYSE:PFE) released topline results from its Phase 3 CREST trial evaluating sasanlimab, an investigational ...
The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the ...
This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...